Judith James to Influenza Vaccines
This is a "connection" page, showing publications Judith James has written about Influenza Vaccines.
Connection Strength
1.575
-
Influenza vaccination can induce new-onset anticardiolipins but not ß2-glycoprotein-I antibodies among patients with systemic lupus erythematosus. Lupus. 2012 Feb; 21(2):168-74.
Score: 0.388
-
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum. 2011 Dec; 63(12):3931-41.
Score: 0.383
-
Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum. 2011 Aug; 63(8):2396-406.
Score: 0.374
-
Antigen nature and complexity influence human antibody light chain usage and specificity. Vaccine. 2016 05 27; 34(25):2813-20.
Score: 0.130
-
Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011 Aug; 121(8):3109-19.
Score: 0.093
-
Individual antibody and T cell responses to vaccination and infection with the 2009 pandemic swine-origin H1N1 influenza virus. J Clin Immunol. 2011 Oct; 31(5):900-12.
Score: 0.093
-
Antibody quantity versus quality after influenza vaccination. Vaccine. 2009 Oct 23; 27(45):6358-62.
Score: 0.083
-
High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination. PLoS One. 2015; 10(5):e0125618.
Score: 0.030